Case report – Cerebraca® Wafer implantation combined with CIK therapy for the treatment of recurrent Glioblastoma revealed superior clinical outcome (overall survival extended for more than 24 months).

← Case report – Cerebraca® Wafer implantation for the treatment of un-resectable cervical spine Glioblastoma resulted in the tumor regression.
Local delivery therapy of Cerebraca® Wafer being highlighted in the natural review →